Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Interventional
×
magrolimab
×
Clear all
Filters
3
NCT05079230
2025-04-04
ENHANCE-3
Gilead Sciences
Phase 3
Terminated
378 enrolled
29 charts
NCT04778397
2025-02-05
ENHANCE-2
Gilead Sciences
Phase 3
Terminated
258 enrolled
25 charts